Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-24 @ 5:12 PM
NCT ID:
NCT07060950
Eligibility Criteria:
Inclusion Criteria:
1. Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage,
2. 18 years old or higher ?
3. Patient who has provided informed, written, and explicit consent,
4. Patient affiliated with a French Social Protection System.
In the case of a tumor biopsy:
5. Tumor considered as accessible by biopsy,
6. Normal hemostasis assessment (PT, APTT, platelets),
7. No anticoagulant or antiaggregant treatment for the biopsy.
Exclusion Criteria:
1. Pregnant woman and/or breast-feeding,
2. Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,
3. Private persons of freedom or under guardianship,
4. Patient with a history of other invasive cancers within the 5 years preceding inclusion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07060950
Study Brief:
Protocol Section:
NCT07060950